{"id": "1358233220593176581", "creation": 1612663009.0, "user_id": "1291533865706758144", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "A study of Oxford/AstraZeneca #vaccine on 2000 patients reports \u201cA two-dose regimen of [the vaccine] didn't show protection against mild/moderate #COVID19 due to [the South African #Variant #B1351]\u201d. Johnson &amp; Johnson &amp; Novavax were also less effective. \n\nhttps://t.co/DHOjC5Dz8k", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#VARIANT", "#B1351"]}